Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication. - Wikidata - wikimedia - TriplyDB

Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.

Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.

http://www.wikidata.org/entity/Q30389591

about

Quantum dots as a platform for nanoparticle drug delivery vehicle design Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA Quantitative analysis of the fate of gold nanocages in vitro and in vivo after uptake by U87-MG tumor cells.Gold nanorods based platforms for light-mediated theranostics.The golden age: gold nanoparticles for biomedicine.Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology.Image guided biodistribution and pharmacokinetic studies of theranostics.Differential recognition of viral RNA by RIG-I.Gold nanorod--siRNA induces efficient in vivo gene silencing in the rat hippocampus.Immune activation efficacy of indolicidin is enhanced upon conjugation with carbon nanotubes and gold nanoparticles Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factor Increasing TNF levels solely in the rat hippocampus produces persistent pain-like symptoms Gold Nanorods Conjugated with Doxorubicin and cRGD for Combined Anticancer Drug Delivery and PET Imaging Halothane modulates the type i interferon response to influenza and minimizes the risk of secondary bacterial pneumonia through maintenance of neutrophil recruitment in an animal model.Adsorption of a Protein Monolayer via Hydrophobic Interactions Prevents Nanoparticle Aggregation under Harsh Environmental Conditions.Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules Respective roles of TLR, RIG-I and NLRP3 in influenza virus infection and immunity: impact on vaccine design.RIG-I like receptors in antiviral immunity and therapeutic applications.Polyelectrolyte-coated gold nanorods and their biomedical applications.Importance of interferon inducible trans-membrane proteins and retinoic acid inducible gene I for influenza virus replication: A review.NLRC5 interacts with RIG-I to induce a robust antiviral response against influenza virus infection.Functionalized Gold Nanoparticles and Their Biomedical Applications.Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer.Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system.RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection.Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response.Prior lung inflammation impacts on body distribution of gold nanoparticles.Applications of gold nanoparticles in the detection and identification of infectious diseases and biothreats.Biomedical applications of gold nanorod-based multifunctional nano-carriers Fabrication of doxorubicin functionalized gold nanorod probes for combined cancer imaging and drug delivery Emerging functional nanomaterials for therapeutics Biosynthesis of Nanoparticles by Microorganisms and Their Applications

P2860

Q26996556-41052EA8-49F8-4EED-8C25-32CD91E165ED Q27335125-87BE7DB1-1D31-4BA7-AA12-C1E1654A3D33 Q28081406-BB0FDE25-A9FA-4CFB-AC81-73C1C6E30AFD Q28394647-04F6679C-2B8E-4888-AC79-B27B88C1B795 Q30444211-38DB0095-1FC1-493A-A36F-63CC3A3A788F Q30457568-6968B56A-74C6-4F6B-ACCC-F6B756F8CCC7 Q34081123-C20C1D3C-C4D0-415A-9389-51EAEAC2EA0B Q34370741-905D6098-F5F9-4836-9B53-A147A520F714 Q34506838-6E5F582A-6142-4611-B6F6-7553A9FB13BC Q35001955-0DA8BDB9-A429-44AC-A706-70A5CF3C95AA Q35093276-E9E9F68E-AC98-4D1A-A325-4018862C6D16 Q35433503-64B5834F-960B-4F86-913C-C83244E74FFC Q35597102-90A5EA24-2087-4A26-8CF2-DA44F1046CDB Q36160364-C9F3123F-F656-44FE-92E7-356105F24477 Q36181664-3951A6BB-BC82-432C-8E5E-DEBC59D9B3DE Q36369118-1D02E64D-6D3A-467A-9996-E4E76F736161 Q37063788-E39D605E-6E34-4CAF-BE7F-0C630D392503 Q37194010-0FB0729B-B13F-4493-93D0-1D94D97C7A61 Q37810600-EE8A64D6-5CEA-494D-A277-8F3D78FC25CB Q37945229-F72A85A1-129D-46DA-B419-8642AE4135CD Q38267205-2F21D01A-5074-49B1-A8E3-3F05BCBC1021 Q38391949-8A93D825-75C1-4B36-BFAA-3E9FAABEB253 Q38939803-3F7A3303-13AB-41CD-AC30-02ED0E57AED0 Q39203522-543C3C4B-009E-47A9-BA73-13502568E779 Q39429999-A57DE212-3D21-4285-AB45-F2948A4F9D60 Q39489674-8AFFAE24-0416-413F-A828-28D12C292749 Q40100763-ACECC1CB-CFAF-423F-9A13-56C86A08DFC4 Q40666130-FC1927AF-E9B4-46F2-973C-BC1E372538B9 Q43240667-7073B5E2-35BE-4339-AE32-9A194360F420 Q51866785-A1DC5018-7689-4A8B-BD4E-961D80780C4D Q57348026-6A2EA1EE-EF2F-4CDD-9684-77ECCBE4ABD0 Q57376428-11EE72BD-64C2-45DB-909C-33829E9A611E Q57376444-33CF5BC7-81A0-4F73-9CE8-109A746C6B33 Q58691642-470B3FC3-E1D5-4F9C-948C-6495344610C0

P2860

Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.

http://www.wikidata.org/entity/Q30389591

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Gold nanorod delivery of an ss ...... 1 influenza viral replication.

@ast

Gold nanorod delivery of an ss ...... 1 influenza viral replication.

@en

type

label

Gold nanorod delivery of an ss ...... 1 influenza viral replication.

@ast

Gold nanorod delivery of an ss ...... 1 influenza viral replication.

@en

prefLabel

Gold nanorod delivery of an ss ...... 1 influenza viral replication.

@ast

Gold nanorod delivery of an ss ...... 1 influenza viral replication.

@en

P1433

Q30389591-DE5F56A9-E5ED-4539-8FF8-9A256CF7A640

P1476

Q30389591-D82EC907-058F-447C-BD2E-465496465A63

P2093

Q30389591-42634F14-09E2-40A4-9FD5-5627C41F6E2E

Q30389591-426630C9-96AC-4685-9C69-D1062136893B

Q30389591-51B17432-1CEF-4752-9740-0C753FC23351

Q30389591-51F7A69B-779D-4FC1-AB7A-A9DA8581191C

Q30389591-5842604D-9C69-4A4B-BC0C-7FE5C4E06B0D

Q30389591-5EDC70EA-D8CE-4E51-94FE-7CE9042F74D6

Q30389591-62DAF773-EBDE-4BED-A9A8-AA24013DDF99

Q30389591-734F1435-48B6-4ABC-B7F0-C515D0AC3560

Q30389591-D5B09771-B78C-4C58-9513-F6A117FBF126

Q30389591-FC83AD7F-3311-4265-98CE-C0B583A6389C

P2860

Q30389591-02BA4D94-DB24-497D-A3AB-75CA11AFA4BB

Q30389591-05F73F0F-B195-497F-84AA-0FB323CB11B0

Q30389591-0AAB7566-1D69-472B-B31F-721498E1C47A

Q30389591-0BCE73E2-8BA9-4FE3-98CC-EC80E8A40AE2

Q30389591-173194B0-B84B-4AE6-B866-090DF5E93848

Q30389591-1896E30C-3989-4468-9953-9171AF439068

Q30389591-381253E7-C3C8-410F-915D-D61E17A286D6

Q30389591-3A186685-29ED-4CD2-A36F-FBB06341016E

Q30389591-492F494F-FB24-4F10-AABF-6D26A9C2E570

Q30389591-4FF1E465-73E6-48BA-A083-41569A963629

P304

Q30389591-81888B4E-218C-4FC5-8729-94222FB8D387

P31

Q30389591-4DAF0FF7-DCE9-41F9-876D-C025469A058E

P356

Q30389591-40CF7E89-E09B-47F2-A9D9-DEA637B91E49

P407

Q30389591-894F29E4-D4C7-485F-9ADC-EF3B47FED320

P433

Q30389591-899C887D-3A5B-486D-89FA-FF831062878E

P478

Q30389591-2BD294CF-5A23-409B-AE0D-0B6C63A7D840

P50

Q30389591-74A26C11-81D2-466F-92E0-5C186DFE7FA4

Q30389591-851B1744-9E78-4FDC-989E-C9ECB92C6A39

P577

Q30389591-1F36816F-FAFC-4467-96B6-2BD2CD07DE00

P5875

Q30389591-B0E6643F-DFC1-4365-8348-18E2D2730514

P698

Q30389591-2B9DB857-F14A-4B6F-9CB4-F07D8F6BF5FC

P921

Q30389591-96640B62-AA46-44C3-8165-65D0AFEAEDB1

Q30389591-C55AD95A-E2BF-4480-A339-52A647A5488C

P932

Q30389591-D4BCBE26-82C9-422F-AE4D-3F4409E2B092

P356

PNAS.0914561107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Gold nanorod delivery of an ss ...... 1 influenza viral replication.

@en

P2093

Adela C Bonoiu

http://www.w3.org/2001/XMLSchema#string

Earl J Bergey

http://www.w3.org/2001/XMLSchema#string

Hong Ding

http://www.w3.org/2001/XMLSchema#string

J Bradford Bowzard

http://www.w3.org/2001/XMLSchema#string

Krishnan V Chakravarthy

http://www.w3.org/2001/XMLSchema#string

Paras N Prasad

http://www.w3.org/2001/XMLSchema#string

Paul R Knight

http://www.w3.org/2001/XMLSchema#string

Priya Ranjan

http://www.w3.org/2001/XMLSchema#string

Suryaprakash Sambhara

http://www.w3.org/2001/XMLSchema#string

William G Davis

http://www.w3.org/2001/XMLSchema#string

P2860

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

5'-Triphosphate RNA is the ligand for RIG-I

VISA is an adapter protein required for virus-triggered IFN-beta signaling

NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I

In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

P304

10172-10177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0914561107

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline M. Katz

P577

2010-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44626120

http://www.w3.org/2001/XMLSchema#string

P698

20498074

http://www.w3.org/2001/XMLSchema#string

P921

P932

2890428

http://www.w3.org/2001/XMLSchema#string